MX2020002894A - Formulaciones transdermicas. - Google Patents

Formulaciones transdermicas.

Info

Publication number
MX2020002894A
MX2020002894A MX2020002894A MX2020002894A MX2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A
Authority
MX
Mexico
Prior art keywords
transdermal formulations
transdermal
formulations
isothiocyanates
isocyanates
Prior art date
Application number
MX2020002894A
Other languages
English (en)
Inventor
Steven Hoffman
Original Assignee
Tyme Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tyme Inc filed Critical Tyme Inc
Publication of MX2020002894A publication Critical patent/MX2020002894A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente descripción está dirigida a composiciones transdérmicas que comprenden isotiocianatos o isocianatos.
MX2020002894A 2017-09-15 2018-09-14 Formulaciones transdermicas. MX2020002894A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762559156P 2017-09-15 2017-09-15
PCT/US2018/051010 WO2019055747A1 (en) 2017-09-15 2018-09-14 TRANSDERMAL PREPARATIONS

Publications (1)

Publication Number Publication Date
MX2020002894A true MX2020002894A (es) 2020-10-07

Family

ID=64267888

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020002894A MX2020002894A (es) 2017-09-15 2018-09-14 Formulaciones transdermicas.

Country Status (13)

Country Link
US (1) US20200405680A1 (es)
EP (1) EP3681476B1 (es)
JP (1) JP2020534272A (es)
KR (1) KR20200052934A (es)
CN (1) CN111328278A (es)
AU (1) AU2018331453A1 (es)
BR (1) BR112020005006A2 (es)
CA (1) CA3075091A1 (es)
EA (1) EA202090732A1 (es)
IL (1) IL273087A (es)
MX (1) MX2020002894A (es)
PH (1) PH12020550081A1 (es)
WO (1) WO2019055747A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200282014A1 (en) * 2019-03-05 2020-09-10 Hoffman Technologies Llc Percutaneous anti-microbiota formulations
EA202193111A1 (ru) 2019-05-14 2022-02-10 Тайм, Инк. Композиции и способы для лечения рака
CA3179419A1 (en) * 2020-04-08 2021-10-14 Hoffman Technologies Llc Methods of treating conditions characterized by insulin deficiency in animals
EP4138579A1 (en) * 2020-04-23 2023-03-01 Vio Chemicals AG Compositions for stabilizing an isothiocyanate
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4091557B2 (ja) * 2003-03-18 2008-05-28 株式会社マンダム 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品
JP5308160B2 (ja) * 2005-11-15 2013-10-09 景▲かい▼ 程 前立腺疾病及び皮膚癌におけるイソチオシアネート系化合物の使用
BE1019434A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Stabilisation du sulforaphane.
JP2014210725A (ja) * 2013-04-18 2014-11-13 小川香料株式会社 Ｔｒｐ活性化組成物
US10010520B2 (en) * 2013-08-13 2018-07-03 Jc (Wuxi) Company, Inc. Combined application of isothiocyanate compound and anti-cancer medicine
EP3237013B1 (en) * 2014-12-23 2023-06-07 Steven Hoffman Transdermal formulations
US9687528B2 (en) * 2014-12-23 2017-06-27 Steven Hoffman Transdermal formulations
CN104559760A (zh) * 2014-12-30 2015-04-29 青岛佳尚创意文化有限公司 一种防腐油漆配方

Also Published As

Publication number Publication date
EP3681476A1 (en) 2020-07-22
JP2020534272A (ja) 2020-11-26
CN111328278A (zh) 2020-06-23
EA202090732A1 (ru) 2020-07-29
BR112020005006A2 (pt) 2020-09-15
US20200405680A1 (en) 2020-12-31
AU2018331453A1 (en) 2020-04-09
IL273087A (en) 2020-04-30
PH12020550081A1 (en) 2020-10-05
EP3681476B1 (en) 2022-09-14
KR20200052934A (ko) 2020-05-15
WO2019055747A1 (en) 2019-03-21
CA3075091A1 (en) 2019-03-21

Similar Documents

Publication Publication Date Title
PH12020550081A1 (en) Transdermal formulations
PL3668937T3 (pl) Kompozycje i zastosowania Z-1-chloro-2,3,3,3-tetrafluoroprop-1-enu
MX2020009347A (es) Picolinamidas como fungicidas.
MX2018008553A (es) Composiciones que contienen alquil poliurea hidroxilo funcional.
PH12019500494A1 (en) Formulations of (r)-2-amino-3-phenylpropyl carbamate
MX2017016405A (es) Reguladores de nrf2.
NZ732799A (en) Picolinamides with fungicidal activity
MX2019011496A (es) Composiciones de niraparib.
PH12017500836A1 (en) Transdermal formulations
TW201614041A (en) Compositions for electronic devices
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
AU2015317715A8 (en) Compositions comprising recombinant Bacillus cells and a fungicide
MX2016011897A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
IL274635A (en) Stable ascorbic acid preparations and methods of using them
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX2019005322A (es) Composiciones de recubrimiento y metodos de uso de las mismas.
MX2020001793A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
MX2020010657A (es) Derivados de oxadiazolina.
MX2017014459A (es) Compuestos de tioeter como inhibidores de la nitrificacion.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2018013184A (es) Composiciones de saponinas y extractos vegetales.
MX2017000862A (es) Formulacion de factor viii.
MX2021006977A (es) Anellosomas y metodos de uso.